Cost of revenue · 2017–2024
Regenxbio cost of revenue
$33.6M−9.8% · FY2024
Regenxbio (RGNX) reported $33.6M in cost of revenue for fiscal 2024, −9.8% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20242024-12-31 | $33.6M | −9.8% | Open → |
| FY20232023-12-31 | $37.2M | −31.8% | Open → |
| FY20222022-12-31 | $54.5M | +5.2% | Open → |
| FY20212021-12-31 | $51.8M | +45.1% | Open → |
| FY20202020-12-31 | $35.7M | +333.4% | Open → |
| FY20192019-12-31 | $8.2M | −14.5% | Open → |
| FY20182018-12-31 | $9.6M | +464.1% | Open → |
| FY20172017-12-31 | $1.7M | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2024 compound annual growth +53.0%
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Regenxbio cost of revenue |url=https://companiesranked.com/en/company/regenxbio/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Regenxbio cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/regenxbio/cost-of-revenueBibTeX
@misc{companiesranked-en-company-regenxbio-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Regenxbio cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/regenxbio/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.